Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Novel embryonic stem cell technology to accelerate genetic research
December 2, 2011
Dr. Bill Stanford
collaborated with Dr. Josef Penninger and other colleagues in Austria to develop and analyze “haploid” mouse embryonic stem cells that have just a single copy of each chromosome, as opposed to the regular two copies. These cells allow researchers to conduct powerful genetic screens very easily, because only one copy of a gene has to be “knocked out” to determine its function. Previously, this kind of research was only possible in yeast, which is not an ideal model for humans. This new technique could dramatically accelerate research into genes involved in many different diseases, and help with the development of new therapies. See
Cell Stem Cell
for details.
This research was supported by the Canadian Institutes for Health Research, the Canada Research Chairs Program, the European Community's Seventh Framework Programme, the European Research Council, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, the Howard Hughes Medical Institute and the Betty Moore Foundation. All research at OHRI is also supported by The Ottawa Hospital Foundation.